Clearance Summary
BioXmark received FDA 510(k) clearance under submission number DEN220017, sponsored by Nanovi A/S. The device was reviewed via the Direct premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2022-12-23.
- Submission: DEN220017
- Applicant / Sponsor: Nanovi A/S
- Clearance pathway: Direct
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.5727
- Decision date: 2022-12-23
Classification & Regulation
This clearance is catalogued under FDA product code QUV and 21 CFR 892.5727, within the Radiology review panel as a Class II device.